| Name | Title | Contact Details |
|---|
Raydian Properties is passionate about creating a better Elder Living experience — the kind we want for our families. We are proud to be NJ’s largest provider of small group home dementia and Alzheimer’s care. We believe there is life beyond a diagnosis and with the right team, our residents can continue having a meaningful journey of a life worth living. Our homes welcome the flow of life with open kitchen, dining, and living spaces. Everyone who works at Raydian Properties is a Care Partner. We believe fresh, wholesome food nourishes both the mind and body. Care Partners prepare all food on-site and we believe in empowering every Care Partner to create joyful living experiences.
Den-Mat Corp has also developed revolutionary LUMINEERS BY CERINATE, the first porcelain laminates that are contact lens-thin and strong, eliminating the need for the shaving and grinding down of sensitive tooth structure.
St. Johns Lutheran Community is a senior living community in Albert Lea, MN that provides short term care, skilled nursing care, independent living, assisted living, and memory care homes.
Reach Fitness Club is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.